Who Owns Ligand Pharmaceuticals Inc
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Ligand Pharmaceuticals Inc.
Who crossed 5% of LGND →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| CONGRESS ASSET MANAGEMENT COCOM658.6K shtrimmed | $205.7M |
| MOODY NATIONAL BANK TRUST DIVISIONCOM NEW13.9K shadded | $4.3M |
| ARGENT CAPITAL MANAGEMENT LLCCOM3.5K shtrimmed | $1.1M |
| Balefire, LLCCOM NEW1K shtrimmed | $318K |
| GAMMA Investing LLCCommon Stock813 shadded | $254K |
| CoreCap Advisors, LLCStock603 shadded | $188.4K |
| GK Wealth Management LLCCOM NEW389 sh— | $121.5K |
| Farther Finance Advisors, LLCStock173 shtrimmed | $54K |
| MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock112 shtrimmed | $35K |
| Retirement Wealth Solutions LLCCOM NEW21 shheld | $6.6K |
| GILPIN WEALTH MANAGEMENT, LLCCOM NEW3 shheld | $938 |
| ARMSTRONG ADVISORY GROUP, INCCOM NEW2 sh— | $625 |
| Davis Capital ManagementStock1 shheld | $312 |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on LGND
Follow Ligand Pharmaceuticals Inc (LGND) by email
New trades in Ligand Pharmaceuticals Inc (LGND) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.